Skip to content

DaVita DVA Preferred Stock, Shares Issued

Preferred Stock, Shares Issued at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH
IQVIA logo
IQVIAIQV

Other financials

Income statement

See full
Revenue$3.4B+6.0%
Operating income$481.9M+9.8%
Net income$197.5M+21.2%
EPS (diluted)$2.87+43.5%

Balance sheet

See full
Cash & equivalents$726.4M+38.5%
Total debt$13.3B+6.7%
Total equity-$755.5M-183%
Total assets$17.5B+2.2%

Cash flow

See full
Operating cash flow$320.8M+78.2%
CapEx$102.0M-28.8%
Free cash flow$218.8M+495%

Valuation

See full
Market cap$13.34B-16.0%
Enterprise value$25.95B-5.5%
P/E17.1×-1.4×
P/S-0.3×

Profitability

See full
Operating margin15.1%-0.7pp
Net margin5.6%-1.0pp
FCF margin10.8%-2.8pp

Returns & leverage

See full
Return on equity159.1%+80.9pp
Debt / equity103.6×+92.8×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by DaVita in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesIssued.

The official record: DaVita’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about DaVita's preferred stock, shares issued.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DaVita's preferred stock, shares issued?
DaVita (DVA) reported preferred stock, shares issued of $0 in Q1 2026.